About Us

Back to About Us

Donna Harrison, M.D.

Associate Scholar

Dr. Donna Harrison is a physician, board-certified in obstetrics and gynecology.  She is currently serving as Executive Director of the American Association of Pro-Life Obstetricians and Gynecologists, the largest non-sectarian pro-life physician organization in the world, with over 4000 members across the United States, and associate members on every continent. Under her leadership, AAPLOG has doubled membership, launched the annual Matthew Bulfin Educational Conference, developed an up to date website and social media presence, and launched systematic outreaches to the medical, legal and policy communities to discuss the effects of abortion on women.

Dr. Harrison’s research interests include Selective Progesterone Receptor Modulators, Endometrial Contraception, Maternal mortality, and Abortion Mortality and Morbidity.  She has authored peer reviewed papers on the approval of RU-486 and on Ulipristal (Ella) as well as on the embryocidal potential of hormonal contraception.  Dr. Harrison is a Continuing Medical Education Speaker in the United States and internationally on topics of Medical Abortion with Mifepristone and Misoprostol, Adverse Events associated with Mifepristone and Misoprostol, Emergency Contraception with Ulipristal, Maternal Mortality, and Abortion Morbidity.

She is an Adjunct Professor at Trinity International University in Deerfield, IL, teaching post graduate seminars at the annual Center for Bio Ethics and Human Dignity summer workshops. She is Associate Editor of the peer reviewed medical journal “Issues in Law and Medicine”.

Dr. Harrison is married to Dr. Mark Harrison, M.D., and is the mother of 5 children and 5 grandchildren.

Latest Research & News

  • Available Resources from the Charlotte Lozier Institute | May 22, 2019

    To view this list as a PDF, see: Available from the Charlotte Lozier Institute   Last updated August 23, 2019.        Special Websites   www.stemcellresearchfacts.org.  This website includes new videos on therapies and cures using ethical sources of stem cells, blogs on current topics, and a search engine for ethical stem cell research […]

  • Abortion Pill Reversal: A Second Chance at Choice | April 17, 2018

    A new and groundbreaking study has thrown the U.S. abortion establishment into a tizzy, and it’s easy to understand why.   For years, proponents of medication abortion (or chemical abortion, as some call it) have criticized a protocol aimed at reversing drug-induced abortions on the primary ground that the number of cases where such reversals […]

  • National Academies Report Downplays the Health Risks of Abortion | March 29, 2018

      Earlier this month, the National Academies of Sciences, Engineering, and Medicine (NAS) released a report on the safety of abortion in the United States. It examines various methods used for abortion and concludes that abortion is safe and poses minimal health risks. The report also puts a negative spin on pro-life laws, arguing that many of […]

  • Rewire’s Reckless Push for Mail-Order Mifeprex | December 1, 2017

    To view this paper as a PDF, see: Rewire’s Reckless Push for Mail-Order Mifeprex   In pursuit of the possibility that abortion drugs could be distributed via pharmacies or mail order shipment for at-home use, researchers from a group called Gynuity Health Projects sought RU-486 online from 20 websites and had them tested for their potency […]

  • Abortion Increases Risk of Preterm Birth: More Evidence in New Publication | May 13, 2016

    The recent systematic review published by Gabrielle Saccone and colleagues joins the long list of over 150 studies over the past four decades which extensively document that having an induced abortion increases a woman’s risk of preterm birth in subsequent pregnancies. Saccone et al. clearly document again what other authors have repeatedly published; a fact also acknowledged by the Institute of Medicine (IOM) in their report on preterm birth in 2005. However, unlike the IOM, who hid the association on page 625 in Appendix B, Saccone places the facts in the open: “Prior surgical uterine evacuation for either I-TOP [induced termination of pregnancy] or SAB [spontaneous abortion] is an independent risk factor for PTB [preterm birth].” Translated, that means any time the womb of a pregnant woman is forced open, there is a risk of damaging the opening of the womb.

  • Good News for Pregnant Moms Diagnosed with Cancer, and Good News for their Unborn Babies | October 20, 2015

    Separation of a mother and her unborn child is tragically sometimes necessary to save the life of the mother. But the number of conditions which truly threaten the mother’s life, and which require a life-saving separation of the mother and her baby are vanishingly small. A new study by Amant and colleagues, entitled “Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy,” brings tremendous hope to pregnant women who have courageously carried their unborn children to birth, despite the need for chemotherapy or radiation therapy. And the successful outcome of these children exposed in utero to radiation, chemotherapy or a combination of both is reassuring to pregnant women who no longer need be told outdated information that they must abort their children or else risk compromising their own care or their child’s life.